The purpose of this study is to explore factors associated with recall of medication education and satisfaction with healthcare provider communication in patients with acute stroke or transient ischemic attack. This is an analysis of data from the AVAIL (Adherence Evaluation of Acute Ischemic Stroke Longitudinal) study. At 3 months after discharge, 2,219 stroke patients from 99 sites were interviewed and asked about their perceptions of education and communication with their healthcare providers as well as their current medication use and knowledge. Results show that less than 2% of the respondents reported not understanding how to take their medications, 4% did not know how to refill their medications, and 5% did not know the reason they were taking them. A vast majority (92%) of participants reported high levels of satisfaction in their communications with healthcare providers after discharge. Although overall understanding and satisfaction was high, older subjects were less likely to recall receiving medication information at discharge or to understand their medications. Similarly, African Americans and patients discharged from an academic hospital were less likely to report receiving a written medication list. This report highlights the success of education efforts and potential areas for additional improvement.
Angie West, RN MSN CCRN CNRN, is the director, Neuroscience/Stroke, at Long Beach Memorial Medical Center, Long Beach, CA.
Margueritte Cox, MS, is a biostatistician at Duke Clinical Research Institute, Durham, NC.
Louise O. Zimmer, MA MPH, is a project leader at Duke Clinical Research Institute, Durham, NC.
Wende Fedder, RN DNP MBA, is the administrative director of Neuroscience at Alexian Brothers Hospital Network, Elk Grove Village, IL.
Cheryl Weber, RN MS CNRN CCRC, is a clinical research coordinator at Rochester General Hospital, Rochester, NY.
Laura Drew, RN BSN, is a clinical research coordinator at Duke Clinical Research Institute, Durham, NC.
Eric D. Peterson, MD MPH, is a professor of medicine at Duke Clinical Research Institute and Duke University Medical Center, Durham, NC.
Cheryl Bushnell, MD MHS, is an associate professor of neurology at Wake Forest School of Medicine, Winston Salem, NC.
Questions or comments about this article may be directed to DaiWai M. Olson, PhD RN, at Olson006@mc.duke.edu. He is an assistant professor of medicine in the Department of Neurology at Duke University Medical Center, Durham, NC.
This research project was supported by unrestricted funds from Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership (BMS/SPP) and conducted through collaboration with the Get With The Guidelines—Stroke program. Adherence eValuation After Acute Ischemic Stroke—Longitudinal (AVAIL) analyses were also supported in part by the Agency for Healthcare Research and Quality (AHRQ) cooperative agreement U18HS016964.
The authors are solely responsible, with approval by the Executive Committee, for the design and conduct of this study, all study analyses, the drafting and editing of the article, and its final contents. The content does not necessarily represent the official views of the AHRQ or BMS/SPP.